Optimal characteristics of agents to treat uncomplicated urinary tract infections

H. C. Neu

doi:10.1007/bf01710012

journal article Jul 01, 1992

Optimal characteristics of agents to treat uncomplicated urinary tract infections

H. C. Neu

Infection Vol. 20 No. S4 pp. S266-S271 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/bf01710012

Topics

No keywords indexed for this article. Browse by subject →

References

48

[1]

Neu, H. C., Parry, M. F. Urinary tract infections — 1982. Use of new concepts to guide therapy. Bull. N. Y. Acad. Med. 59 (1983) 283–300.

[2]

Hooton, T. M. Epidemiology, definitions, and terminology in urinary tract infections. In:Neu, H. C., Williams, J. D. (eds): New Trends in Urinary Tract Infections. Karger, Basel 1990, pp. 1–8.

[3]

Fihn, S. D., Stamm, W. E. Interpretation and comparison of treatment studies for uncomplicated urinary tract infections in women. Rev. Infect. Dis. 7 (1985) 468–478. 10.1093/clinids/7.4.468

[4]

Norrby, S. R. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev. Infect. Dis. 12 (1990) 458–467. 10.1093/clinids/12.3.458

[5]

Rubin, R. H. Infections of the urinary tract. Sci. Am. Med. 23 (1984) 1–12.

[6]

Kass, E. H. Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract. Am. J. Med. 18 (1955) 764–781. 10.1016/0002-9343(55)90190-x

[7]

Stamm, W. E. Quantitative urine cultures revisited. Eur. J. Clin. Microbiol. Infect. Dis. 3 (1984) 279–281.

[8]

Stamm, W. E. Criteria for the evaluation of antimicrobial drug efficacy in uncomplicated UTI — a problem of definitions and individualization. In:Ohkoshi, M., Kawada, Y. (eds): Clinical Evaluation of Drug Efficacy in UTI. Excerpta Medica, Amsterdam 1990, pp. 157–172.

[9]

Stamm, W. E., Counts, G. W., Running, K. R., Finn, S., Turck, M., Holmes, K. K. Diagnosis of coliform infections in acutely dysuric women. N. Engl. J. Med. 303 (1980) 409–415. 10.1056/nejm198008213030801

[10]

Fihn, S. D., Johnson, C., Roberts, P. L., Running, K., Stamm, W. E. Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10- day course. A double-blind randomized trial. Ann. Intern. Med. 108 (1988) 350–357. 10.7326/0003-4819-108-3-350

[11]

Stamey, T. A., Govan, D. E., Palmer, J. M. The localization and treatment of urinary tract infections: the role of bactericidal urine levels as opposed to serum levels. Medicine 44 (1965): 1–36. 10.1097/00005792-196501000-00001

[12]

Neu, H. C. Single-dose treatment of urinary tract infections. A pharmacologist's view. In:Bailey, R. (ed.): Single-dose therapy of urinary tract infection. ADIS Health Sci. Press, Auckland 1983, pp. 92–97.

[13]

Stamey, T. A. The role of introital enterobacteria in recurrent urinary infections. J. Urol. 109 (1973) 467–472. 10.1016/s0022-5347(17)60454-3

[14]

Stamey, T. A., Condy, M., Mihara, G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary tract infections: biological effects on the vaginal and rectal flora. N. Engl. J. Med. 296 (1977) 780–782. 10.1056/nejm197704072961403

[15]

Neu, H. C. Contribution of beta-lactamases to bacerial resistance and mechanism to inhibit beta-lactamases. Am. J. Med. 79 Suppl. 5B (1985) 2–11.

[16]

Towner, K. J., Wise, P. J. Transferable resistance plasmids as a contributory cause of increasing trimethoprim resistance in general practice. J. Antimicrob. Chemother. 11 (1983) 33–39. 10.1093/jac/11.1.33

[17]

Murray, B. E., Alvarado, T., Kim, K. H. Increasing resistance to trimethoprim-sulfamethoxazole among isolates ofEscherichia coli in developing countries. J. Infect. Dis. 152 (1985) 1107–1113. 10.1093/infdis/152.6.1107

[18]

Andriole, V. T. Use of quinolones in treatment of prostatitis and lower urinary tract infections. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 342–350. 10.1007/bf01967009

[19]

Neu, H. C. Penicillins. In:Mandell, G., Douglas, G., Bennett, J. (eds): Principles and Practice of Infectious Diseases. 3rd ed. Churchill Livingstone, New York 1990, pp. 230–246.

[20]

Fang, L. S. T., Tolkoff-Rubin, N. E., Rubin, P. H. Efficacy of single-dose and conventional amoxicillin therapy in urinary tract infections localized by the antibody-coated bacteria technique. N. Engl. J. Med. 298 (1978) 413–416. 10.1056/nejm197802232980802

[21]

Harbord, R. B., Grüneberg, R. N. Treatment of urinary tract infection with a single-dose of amoxycillin, co-trimoxazole, or trimethoprim. Br. Med. J. 283 (1981) 1301–1302. 10.1136/bmj.283.6302.1301

[22]

Bailey, R. R. Review of the published studies on single-dose therapy of urinary tract infections. Infection 18 Suppl. 2 (1990) 853–856.

[23]

Savard-Fenton, M., Fenton, B. W., Reller, L. B., Lauer, B. A., Byny, R. L. Single-dose amoxicillin therapy with follow-up urine cultures. Effective initial management for acute uncomplicated urinary tract infections. Am. J. Med. 73 (1982) 808–813. 10.1016/0002-9343(82)90762-8

[24]

Sandberg, T., Henning, C., Iwarson, S., Paulson, O. Cefadroxil once daily for three or seven days versus amoxycillin for seven days in uncomplicated urinary tract infections in women. Scand. J. Infect. Dis. 17 (1985) 83–87. 10.3109/00365548509070425

[25]

Neu, H. C. The pharmacokinetics of bacampicillin. Rev. Infect. Dis. 3 (1981) 117–120. 10.1093/clinids/3.1.117

[26]

Hooton, T. M., Running, K., Stamm, W. Single-dose therapy of cystitis in women. A comparison of trimethoprim-sulfamethoxazole, amoxicillin, and cyclacillin. JAMA 253 (1985) 387–390. 10.1001/jama.1985.03350270085027

[27]

Neu, H. C. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria. Antimicrob. Agents Chemother. 9 (1976) 793–799. 10.1128/aac.9.5.793

[28]

Marsh, B. T., Obst, D., Menday, A. P. Comparative efficacy of 3-day and 7-day chemotherapy with pivmecillinam in urinary tract infections in general practice. J. Int. Med. Res. 8 (1980) 105–111. 10.1177/030006058000800201

[29]

Gordon, A., Kalima, S., Mäkälä, P., Antikainen, R. Comparison of three day and ten day regimen with sulfadiazine-trimethoprim combination and pivmecillinam in acute lower urinary tract infections. Scand. J. Infect. Dis. 19 (1987) 97–102. 10.3109/00365548709032384

[30]

Greenberg, R. N., Reilly, P. M., Luppen, K. L., Keinnadt, W. J., Ellington, L. I., Bollinger, M. R. Randomized study of single-dose, three day, and seven day treatment of cystitis in women. J. Infect. Dis. 153 (1986) 277–282. 10.1093/infdis/153.2.277

[31]

Brumfitt, W., Hamilton-Miller, J. M. T., Smith, G. W. Comparative trial of cefuroxime axetil in recurrent urinary tract infections. Antimicrob. Agents Chemother. 31 (1987) 1442–1443. 10.1128/aac.31.9.1442

[32]

Brogden, R. N., Campoli-Richards, D. M. Cefixime: a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 38 (1989) 524–550. 10.2165/00003495-198938040-00004

[33]

Brittain, D. C., Scully, B. E., Hirose, T., Neu, H. C. The pharmacokinetic and bactericidal characteristics of oral cefixime. Clin. Pharm. Ther. 38 (1985) 590–594. 10.1038/clpt.1985.229

[34]

Bailey, R. B., Peddie, B. A. Comparison of single-dose netilmicin with a five-day course of co-trimoxazole for uncomplicated urinary tract infection. NZ Med. J. 97 (1984) 262–264.

[35]

Gossius, G., Vorland, L. Randomized comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulphamethoxazole for acute cystitis in women. Scand. J. Infect. Dis. 16 (1984) 373–379. 10.3109/00365548409073963

[36]

Fihn, S. D., Johnson, C., Roberts, P. L., Running, K., Stamm, W. E. Trimethoprim-sulfamethoxazole for acute dysuria in women, a single-dose or 10-day course. A double-blind randomized study. Ann. Intern. Med. 108 (1988) 350–357. 10.7326/0003-4819-108-3-350

[37]

Neu, H. C. The quinolones. Infect. Dis. Clin. N. Am. 3 (1989) 625–640. 10.1016/s0891-5520(20)30293-2

[38]

Naber, K. G. Use of quinolones in urinary tract infections and prostatitis. Rev. Infect. Dis. 11 Suppl. (1989) 1321–1337. 10.1093/clinids/11.supplement_5.s1321

[39]

Kosmidis, J., Gargalianos, P., Adamis, G., Petropoulou, D., Markis, D. Fleroxacin in single-dose oral therapy of uncomplicated urinary tract infection. J. Antimicrob. Chemother. 22 Suppl. D (1988) 219–221. 10.1093/jac/22.supplement_d.219

[40]

Ode, B., Walder, M., Forsgren, A. Failure of a single-dose of 100 mg ofloxacin in lower urinary tract infections in females. Scand. J. Infect. Dis. 19 (1987) 677–679. 10.3109/00365548709117203

[41]

Naber, K. G., Thyroff-Friesinger, U. Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study. Infection 17 Suppl. 2 (1990) S 70-S 76. 10.1007/bf01643431

[42]

Neu, H. C. Fosfomycin trometamol — management of lower urinary tract infections. Chemotherapy 36 Suppl. 1 (1990) 53–55. 10.1159/000238819

[43]

Segre, G., Bianchi, E., Cataldi, A., Zannini, G. Pharmacokinetic profile of fosfomycin trometamol (Monuril). Eur. Urol. 13 Suppl. (1987) 56–63. 10.1159/000472864

[44]

Carlae, N. A., Borsotto, M., Cuffini, A. M., Savoia, D. Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents. Eur. Urol. 13 Suppl. 1 (1987) 86–91. 10.1159/000472869

[45]

Neu, H. C. Fosfomycin trometamol versus amoxycillin single-dose multicenter study of urinary tract infections. Chemotherapy 36 Suppl. 1 (1990) 10–18.

[46]

Crocchiolo, P. Single-dose fosfomycin trometamol versus multiple-dose co-trimoxazole in the treatment of lower urinary tract infections in general practice. Chemotherapy 36 Suppl. 2 (1990) 37–40. 10.1159/000238815

[47]

Jardin, A. A general practitioner multicenter study: fosfomycin trometamol single-dose versus pipemidic acid multiple dose. Infection 18 Suppl. 2 (1990) 89–93. 10.1007/bf01643434

[48]

Boerema, J. B. J., Willems, F. T. C. Fosfomycin trometamol in a single-dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice. Infection 18 Suppl. 2 (1990) 80–87. 10.1007/bf01643433

Cited By

17

DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION

Thomas M. Hooton, Walter E. Stamm · 1997

Infectious Disease Clinics of North...

Metrics

17

Citations

48

References

Details

Published: Jul 01, 1992
Vol/Issue: 20(S4)
Pages: S266-S271
License: View

Authors

H

H. C. Neu

Cite This Article

H. C. Neu (1992). Optimal characteristics of agents to treat uncomplicated urinary tract infections. Infection, 20(S4), S266-S271. https://doi.org/10.1007/bf01710012

Optimal characteristics of agents to treat uncomplicated urinary tract infections

You May Also Like